How healthy is your heart?

Coronary artery disease is the most common type of heart disease. Radiologists at University Radiology are using the HeartFlow Analysis to non-invasively test their patients for coronary artery disease. This advanced technology provides a personalized digital 3D model of a patient's coronary arteries that shows the impact that blockages have on blood flow to the heart.

Coronary CTA + the Heartflow FFRCT Analysis - A Better Pathway

Coronary CTA enables clinicians to non-invasively visualize a patient's coronary artery disease (CAD), but what happens when it's unclear if the disease is impacting blood flow?

This is where the HeartFlow FFRCT Analysis can help:

• Without additional patient tests, the HeartFlow Analysis quickly and non-invasively delivers functional information (FFRCT values) about each blockage.

• Completing the picture for each patient leads to better clinical decision-making and improved patient outcomes.1

• Recognized in ACC/AHA Chest Pain Guidelines to help guide treatment for patients with CAD.

A Proven Solution - See the HeartFlow Difference

Increases diagnostic confidence

CCTA+FFRCT delivers better per-vessel diagnostic performance than other non-invasive cardiac tests.2

See what might be missed

CCTA+FFRCT identifies disease other non-invasive cardiac tests may overlook.2,3

Avoid the unnecessary

CCTA+FFRCT enables physicians to confidently identify patients who can be treated with optimal medical therapy alone.4

Help every patient own their heart health

CCTA+FFRCT enables physicians to provide patients with a visual understanding of their disease and impact it has on their heart.

1. Curzen, N.P., et al., J Am Coll Cardiol 2016. Newby D.E., et al. N Engl J Med 2018.

2. Driessen, et al. J Am Coll Cardiol 2019. Norgaard, et al, Euro J Radiol 2015.

3. Melikian, et al. JACC: Cardiovasc Interv 2010. Jung, et al. Euro Heart J 2008. Koo, et al. J Am Coll Cardiol 2011. Min, et al. JAMA 2012. Nørgaard, et al. J Am Coll Cardiol 2011.

4. Patel, et al. J Am Coll Cardiol 2019.